Soc. Generale Knock-Out 1N8/ DE000SW3QS32 /
11.06.2024 8:58:47 | Изменение-0.15 | Бид13:21:52 | Предложение13:21:52 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
13.85EUR | -1.07% | 13.85 Величина цены спроса: 10,000 |
13.86 Величина цены предложения: 10,000 |
ADYEN N.V. E... | 527.3034 EUR | 31.12.2078 | Call |
GlobeNewswire
13:31
HUM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Human...
GlobeNewswire
13:30
Sonder Holdings Inc. Announces Amendment to Financing Agreement and Provides Update on Portfolio Opt...
GlobeNewswire
13:30
Agrify Corporation Announces $500K Turnkey Extraction Equipment Deal with Grotech Farms LLC in Bridg...
GlobeNewswire
13:18
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Clas...
GlobeNewswire
13:15
AppTech Payments Announces Strategic Partnership with FISB Solutions to Upgrade Legacy Banking Syste...
GlobeNewswire
13:05
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
GlobeNewswire
13:05
Banks are making climate commitments, but are they actually making a difference?
GlobeNewswire
13:03
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectiv...
GlobeNewswire
13:00
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil
GlobeNewswire
13:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...
GlobeNewswire
13:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2...
GlobeNewswire
13:00
Republic enhances tokenized asset accessibility with Zero Hash's fiat and USDC payment rails
GlobeNewswire
13:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница